The MLL gene is frequently involved in chromosomal translocations associated with high-risk acute leukaemia. Infant and therapy-related acute leukaemia patients display chromosomal breakpoints preferentially clustered in the telomeric portion of the MLL breakpoint cluster region (SCII). Here, we demonstrate that SCII colocalizes with a gene-internal promoter element in the mouse and human MLL gene, respectively. The mRNA generated encodes an N-terminally truncated version of MLL that still exhibits many functional regions, including the C-terminal SET-domain. Etoposide-induced DNA doublestrand breaks colocalize with the binding site of RNA polymerase II and the transcription initiation region, but not with a nearby Topo II consensus sequence. Thus, the observed genomic instability of the human MLL gene is presumably linked to transcriptional processes. The consequences of this novel finding for the creation of chromosomal translocations, the biology of the MLL protein and for MLL-mediated acute leukaemia are discussed.
Introduction
Chromosomal translocations of the human MLL gene are recurrently associated with the disease phenotype of high-risk acute leukaemias (acute lymphoblastic leukaemia -ALL and acute myeloid leukaemia -AML).
Chromosomal breakpoints of leukaemia patients were identified within a genomic area flanked by MLL exons 8 and 14 (Mitterbauer-Hohendanner and Mannhalter, 2004) . Within this region of the MLL gene, two recombination hot spots have been identified: centromeric subcluster I (SCI) and telomeric subcluster II (SCII). Breakpoints in SCII are preferentially found in infant ALL and secondary leukaemia patients (Broeker et al., 1996; Strissel et al., 1998; Reichel et al., 2001) . This raises the question about the molecular mechanisms, which result in these illegitimate recombination events. Experiments in a murine model system have revealed that DNA double-strand breaks (DSBs) are the prerequisite for the creation of chromosomal translocations (Richardson and Jasin, 2000) and the subsequent DNA repair process is mediated by the NHEJ (nonhomologous end joining) pathway. The latter process results in specific signatures that can be identified at MLL chromosomal fusion sites (Reichel et al., 1998; Gillert et al., 1999) . However, these experiments did not reveal what makes the SCII region of the MLL gene vulnerable for such illegitimate recombination events.
The first evidence for an intrinsic mechanism leading to genetic instability of the human MLL gene came from clinical observations. The use of epipodophyllotoxins in a chemotherapy regimen results in therapy-related acute leukaemia associated with translocations of the human MLL gene (Goto et al., 1994; Nasr et al., 1997) . Subsequently, in vitro experiments demonstrated that certain cytotoxic drugs, topoisomerase II inhibitors, or CD95-mediated apoptosis are all able to induce DNA DSBs within SCII (Aplan et al., 1996; Stanulla et al., 1997; Felix et al., 1998; Andersen et al., 2001; Betti et al., 2001 Betti et al., , 2005 Sim and Liu, 2001; Libura et al., 2005) . Further clues came from experiments that demonstrated DNase I hypersensitivity of SCII (Strissel et al., 1998) and elevated histone acetylation along MLL exons 11 and 14 (Khobta et al., 2004) . Here, we performed Affymetrix gene expression profiling experiments that revealed Mll transcripts present in an established Mll k.o. cell line (MLL À/À ; Yu et al., 1995) , where we observed only a 2.3-to 3.4-fold reduction of Mll transcription at two different probe sets. Therefore, we investigated transcription of the murine Mll gene in MLL À/À and wild-type cells. Additional experiments performed in human cells indicated that the recombination hot spot SCII coincides with a novel gene-internal promoter of the human MLL gene.
Results

Identification of Mll transcripts in the established
Mll k.o. line Gene expression profiling experiments were performed using an established cell line derived from a homozygous Mll k.o. strain and its isogenic wild-type control (Yu et al., 1995) . About 2000 genes were significantly deregulated in Mll k.o. cells (820 genes decreased: 2-to 613-fold, 1171 genes increased: 2-to 2210-fold). Within the population of downregulated genes, we identified the Mll gene itself. Transcription of the Mll gene in MLL À/À cells was only decreased for about 2.3-to 3.4-fold relative to wild-type cells (see Figure 1 : log 2 -changes were À1.22 and À1.78, respectively). This unusual finding provoked us to analyse the Mll k.o. line in more detail, especially to examine all transcripts derived from the knock-out Mll alleles.
Mapping Mll transcripts in the Mll k.o. line
To investigate the transcriptional properties of the Mll k.o. alleles, several reverse transcription-polymerase chain reaction (RT-PCR) experiments were performed. First, the in-frame fusion of Mll exon 1-4::lacZ was tested. As shown in Figure 2a , transcripts starting from the endogenous Mll promoter were spliced correctly with the lacZ transgene (lanes 1-4). This endogenous Mll transcript terminates at the predicted transcriptional stop signal and read through was not observed (lane 5). Next, we investigated the transcription of the knockedin NeoR gene (Figure 2b, lane 6) . This transcript was terminated correctly at its poly-A site (lane 7). A transcript containing Mll exons 12-37 was identified ( Figure 2c , lanes 11-15), however, upstream Mll exons were not involved (lanes 8, 9), although wild-type cells show such transcripts (lane 16). Finally, we tested for alternative splice products including either Mll exons 1-4, lacZ or the NeoR gene, however, no such splice products involving Mll exon 12 could be detected (Figure 2d, . This indicated that the observed transcript including Mll exons 12-37 was not arising due to the disruption strategy and/or artificial splicing rather than by de novo RNA synthesis.
Localizing the gene internal promoter element of the Mll gene To map the location of a putative promoter element, several RT-PCR analyses were performed. The use of nuclear total RNA was misleading because intron 11 sequences were frequently contained in the isolated nucleic acids, indicating for late splicing of Mll intron 11 (data not shown). Only by using cytosolic mRNA, Mll transcripts could be identified with an oligonucleotide that contained the last nucleotides of intron 11 and the first nucleotides of exon 12 (Figure 3 ). This suggested that a cryptic promoter element must be located upstream of exon 12 of the murine Mll gene. Therefore, we cloned a genomic region containing Mll intron 11 (B500 bp), exon 12 (147 bp) and intron 12 (312 bp) into a promoterless Luciferase plasmid (A m ). Several potential transcription factor binding sites were identified by in silico analyses (MatInspector V2.2, Quandt et al., 1995 ; TESS, by Schug und Overton . see http://www. cbil.upenn.edu/cgi-bin/tess/tess) in the vicinity of the putative transcription initiation site and the corresponding downstream area (intron 12). Therefore, two additional genomic DNA fragments (B m , C m ) were cloned into the Luciferase reporter plasmid and subsequently transfected in 293T cells (Figure 4a, upper panel) . Spliced Mll Á Luciferase fusion transcripts were detected using oligonucleotides specific for the Mll exon 12 and the Luciferase gene (see Figure 4b , upper panel). All measured Luciferase activities were normalized against alkaline phosphatase activity (internal control) and correlated to the SV40-promoter::Luciferase activity. The obtained results indicated the presence of a cryptic promoter element within Mll intron 11 that could be enhanced by sequences derived from Mll intron 12, however, no fine mapping of the promoter element was performed.
In order to verify these findings for the human system, all experiments were repeated with corresponding genomic regions of the human MLL gene (A h -C h ; see Figure 4a , lower panel). To determine whether any functional similarity between both sequences exists, we used three oligonucleotides that specifically bind either to intron 11, to the intron11/exon 12 boundary or to exon 12. This was a repetition of the experiment shown in Figure 3 , and again, spliced MLL . Luciferase fusion transcripts were observed for two primer sets (see Figure 4b , lower panel). Comparison of murine and human promoter activities revealed an increase of about B60%. Deletion of intron 12 sequences always resulted in a 40-60% reduction of Luciferase activities. Deletion of the potential basic promoter elements located in intron 11 abolished Luciferase activity to Figure 1 Gene expression profiling of wild-type and MLL À/À cells. Total RNA isolated from MLL À/À and isogenic wild-type cells were probed on the Affymetrix Chip 430 2.0. A total of 1991 deregulated genes were identified, of which 820 were down-(B40%) and 1171 were upregulated (B60%). Upper panel: the number and distribution of deregulated genes according to their log 2 -changes is shown. Lower panel: within the group of 512 genes (downregulated 2-to 4-fold), transcription of the Mll gene in MLL À/À cells was identified at two probe sets (1427283_at and 1452377_at, respectively) with significant P-values (0.99998 and 0.999977, respectively). The downregulation of Mll transcripts was in the range of B2.3-to B3.5-fold (Dlog 2 of -1,22 and -1,78, respectively). levels measured for the negative controls (see Figure 4c ). This demonstrated that both mammalian MLL genes exhibit a cryptic gene-internal promoter element, and their activities seem to be independent from their normal genomic context.
The gene-internal transcript encodes the Mll* protein As transcription initiation was observed for both mammalian systems, we next investigated whether the murine mRNA transcripts can be translated into protein (human MLL k.o. cells are not available). For this purpose, we first analysed the open reading frame for potential translational start sites. Three potential AUG translational start codons (according to Kozak's rule) were identified at Mll codons 1647 (Mll exon 17), 1685 (Mll exon 18) and 1694 (Mll exon 19), respectively. If any of these start codons were used for translation, the resulting polypeptide chain was predicted to be cleaved into an Mll* . N and Mll . C protein fragment by Taspase1 (Yokoyama et al., 2002; Hsieh et al., 2003) . The resulting Mll* . N protein would have a molecular weight (MW) between 95 and 100 kDa. Indeed, a protein with an apparent MW of 97 KDa was observed in nuclear extracts of wild-type and MLL À/À cells (see Figure 5a , upper panel, S450 fractions) by using the monoclonal antibody (MAB) E28. This indicated that one of the above-mentioned AUG start codons was used for translation and the resulting steady-state levels of Mll* protein were similar in both investigated cell lines. The presence of the Mll . C protein fragment in both cell lines was verified by immunoprecipitation and subsequent Western blot analyses with the polyclonal antisera (PAS) 173 (see Figure 5a , lower panel). This demonstrated that (1) the Mll* transcript can be translated into the Mll* protein, (2) this property of the Mll gene can be detected in wild-type and Mll k.o. cells, and (3) the geneinternal promoter is not a cryptic promoter rather than a bona-fide property of the murine Mll gene.
We also performed immunohistochemical studies by using the MAB E3 and MAB E28, respectively. As shown in Figure 5b , distinct signatures were obtained for the MLL À/À and MLL þ / þ cell lines. A clear-cut interpretation is difficult, because the Mll and Mll* protein are both cleaved into two protein fragments (Mll . N and Mll . C; Mll* . N and Mll . C). The wild-type Mll . N fragment was found in a speckled distribution within the nucleus, whereas the Mll . C fragment is strongly enriched in the perinuclear region ( Figure 5b , upper 4 panels). In MLL À/À cells, MAB E3 recognizes the Mll . lacZ fusion protein that seems to be distributed in a pattern similar to Mll . N in wild-type cells. However, the MAB E28 antibody recognizes completely redistributed Mll fragments in the k.o. line ( Figure 5b , lower 4 panels). The observed relocalization might be explained by the absence of bona-fide Mll . N protein fragments. This presumably enables the Mll* . N Figure 4 Luciferase reporter gene experiments. (a) Both gene-internal promoter elements exhibit standard motifs (G ¼ GC-Box, C ¼ CAAT-Box, T ¼ TATA-Box) and potential transcription factor binding sites according to MatInspector V2.2 and TESS database researches (1: cEts-2, YY1, 2 Â Sp1, Ikaros1; 2: Gata1, Hunchback, c-Myb; 3: Gata1, Ikaros1, Gata1; 4: 2 Â Sp1; 5: c-Myb, Gata1, Ikaros1; 6: c/EBPa, Gata1, Oct1, 2 Â Gata1; 7: Sp1, YY1, Hunchback, Sp1; 8: Sp1, Pu Á 1, Gata1; 9: AML1, 2 Â Hunchback; 10: cEts-1, Oct1, YY1, Oct1, c-Myb, Gata1; 11: Gata1, c-Myb). fragment to bind to MLL . C protein fragments localized at subnuclear regions inside the nucleus.
Histone modifications revealed an active chromatin state at Mll exon 12 As histone modifications play a crucial role for transcription (for a review see Margueron et al., 2005) , we investigated the properties of chromatin in the vicinity of Mll exon 12 in MLL À/À cells. ChIP experiments were performed by using antisera specific for RNA Polymerase II and two different histone modifications (H3K4; H3K9). By using probe sets upstream, at and downstream of Mll exon 12 (probe sets A-C), the presence of RNA polymerase II and tri-methylyted H3K4 was only observed for regions involved in the production of the gene-internal transcript, whereas the region upstream of the putative transcription initiation site displayed the signature of inactive chromatin (dimethylated H3K9). Thus, the region directly upstream of Mll exon 12 seems to bind RNA Polymerase II and exhibits a chromatin structure that can be actively transcribed (see Figure 6 ). In wild-type cells, a trimethylated H3K4 and a polymerase II signature was observed for all three probesets A-C, while the H3K9 signature upstream of Mll exon 12 could not be observed (data not shown).
In situ hybridization experiments using mouse sections of different developmental stages In order to test the possibility that the Mll* transcript has a temporary function during embryogenesis, or, is even expressed in the absence of full-length Mll mRNA, we used mouse sections from different developmental stages to analyse for Mll transcription (see Figure 7) . In particular, we were interested in identifying stages during development, where only Mllex28-hybridized sections were positive, while Mllex4-hybridized sections remain negative. However, as judged from the in situ hybridization and RT-PCR experiments, we have to conclude that full-length Mll and Mll* transcripts are always coexpressed during all investigated developmental stages (E9.5, E11.5, E13.5, E15.5 and E17.5).
Etoposide-induced DNA DSBs within the human MLL gene colocalize with the RNA polymerase binding site mapped within the murine Mll gene The Luciferase reporter gene experiments revealed that mouse Mll and human MLL sequences exhibited similarity in their gene-internal promoter elements and their ability to initiate transcription. Therefore, inverse PCR experiments were performed to determine where DNA DSBs actually occur within the MLL SCII region upon etoposide treatment. Different human cell lines and freshly prepared human peripheral blood mononuclear cells (PBMCs) were treated with 20 mM VP16 (etoposide) for 16 h. Genomic DNA was isolated from treated and untreated cells and subsequently analysed after restriction and self-ligation by inverse PCR. A similar method to identify such DNA DSBs has been published recently (Betti et al., 2001) . A population of small PCR fragments were obtained which indicated DNA DSBs in the vicinity of exon 12. This population of PCR fragments was cloned and about 170 individual clones were analysed by DNA sequencing. The analysis revealed that all DNA DSBs were scattered in an area of about 100 bp, overlapping with the mapped RNA polymerase II binding region identified in the murine Mll gene. As homologous regions of mouse and human intron 11 were functional in the reporter gene assays, we pose the hypothesis that the RNA polymerase binding site/transcription initiation site at the intron 11/exon 12 borderline is the target for etoposide-mediated DNA DSBs in human cells. A perfect Topo II consensus site located within MLL exon 12 was not affected by the etoposide treatment, since DNA DSBs -indicative for endogenous Topo II activity -were observed more in untreated controls than in treated cells (see Figure 8 ).
Discussion
Here, we describe for the first time that the murine Mll gene contains a gene-internal promoter element that became overt in an embryonic fibroblast cell line established from the homozygous Mll k.o. mice (Yu et al., 1995) . As this novel promoter gives rise to a transcript that seems to start in vicinity of exon 12, we first excluded all possibilities of alternative splicing. However, our data indicated that the identified RNA transcript (spanning Mll exons 12-37) is a bona-fide transcript that originated due to a gene-internal promoter element. The mRNA transcript, termed Mll*, encodes a protein with a MW of about 230 kDa. For translation, an in-frame AUG start codon is used that seems to be located either in Mll exon 17, 18 or 19, respectively. The 230 kDa gene product is cleaved by Taspase1, as demonstrated by two protein species with a MW of about 97 kDa and the presence of the Mll . C fragment (p180).
Searches performed in the EST database did not provide any evidence for the existence of the Mll* transcript. Presumably, the presence of the gene-internal transcript remained uncovered because of the similarities of the full-length MLL and the new Mll* transcript. The start site is located at the intron 11/exon 12 borderline; such a transcript would be characterized as an unspliced hnRNA fragment of the Mll gene. Without any further investigation, it is therefore impossible to define it as a bona-fide transcript. However, the presence of Mll transcript signals on the Affymetrix 430 2.0 chip (probe sets 1452377_at and 1427283_at), the RT-PCR experiments demonstrating the presence of the Mll exon 12-37 transcript and the protein production led to the conclusion that the Mll* transcript and the encoded Mll* protein is not a technical artifact, or an artefact of Mll À/À cells due to the disruption of the Mll gene rather than a novel RNA species encoded by the murine Mll gene.
Although no human MLL k.o. model is available, we tried to dissect whether the human MLL gene provides similar properties. Gene reporter experiments performed in human 293T cells resulted in spliced MLL::Luciferase mRNA products and yielded Luciferase activity, regardless whether the DNA fragments were obtained from the mouse or the human MLL gene. The human sequences resulted even in much higher Luciferase activities, suggesting that human gene-internal promoter element is much stronger than the corresponding gene-internal mouse promoter. However, further analyses in human cells are hampered by the fact that no human MLL k.o. system is available. Using human wild-type cells, it is impossible to draw any conclusions from data obtained by Primer extension experiments or other techniques (S1-mapping) normally used for promoter analysis (see above: EST problem; late splicing of intron 11). Even investigations of the protein level are difficult, because many fast migrating bands react with antibodies directed against different MLL epitopes (data not shown). Therefore, we have initiated a new project aiming to establish monoclonal antibodies directed against specific MLL regions, which should allow us to address this specific question in the future.
The etoposide experiments performed in a human proB cell line (REH), a human proT cell line (Jurkat), and in freshly prepared peripheral mononuclear cells indicated that DNA DSBs are located upstream of the proposed transcriptional initiation region. Assuming that RNA polymerase II is bound to this area, there should be a stretch of about 100 nucleotides that is free of any nucleosomes. This idea is in line with a DNase I hypersensitive site mapped to the same area (Strissel et al., 1998) , and the observed histone modifications in this region of the MLL breakpoint cluster region (Khobta et al., 2004) .
Based on the presented data, we pose the hypothesis that DNA DSBs occurring in the SCII region of the human MLL gene are directly linked to the activity of the gene-internal promoter. In general, open chromatin structures that permit transcription are a common requirement for recombination events (Blackwell et al., 1986; Rabbitts, 1994) . Thus, the gene-internal promoter may predispose the human MLL gene to genetic instability. The stronger activity of the human geneinternal promoter can presumably be attributed to a stronger enhancer activity mapped to intron 12. The difference between mouse and human intron 12 is the presence of the repetitive MER2 and ALU elements. If so, the observed differences in transcriptional activitiesand therefore the intrinsic genetic instability -is a direct consequence of divergent genome evolution. The proposed hypothesis is in line with recent findings that even small transcription units, for example, miRNAs, are located directly at fragile sites or chromosomal breakpoints (see Calin et al., 2004) .
The presence of a gene-internal promoter within the murine and human MLL gene has a number of consequences:
(1) MLL genes express two protein variants: a fulllength protein and an N-terminally truncated version thereof. The shorter protein variant exhibits neither the AT-hooks, the MT-nor the plant homeodomain (PHD) 1-3 -domains. However, it still retains the bromo-, the PHD 4 -, the FYRN-, the TA-, the MOF binding site, the FYRC-and the SET-domain. This shorter Mll protein variant may still exhibit H3K4 histone methyltransferase activity due to the presence of the SET-domain. Yet unclear is whether the Mll* . N and Mll . C protein fragments are able to directly interact with each other. However, the observed redistribution of Mll* . N protein fragments in the nucleus of MLL À/À cells argues either for an interaction between Mll* . N and Mll . C, or, for an interaction of Mll* . N with yet unknown nuclear/chromatin factors. However, the Mll* protein does not encode the N-terminal sequences of Mll which confer binding to Menin1, and thus, 'promoter selectivity' to the wild-type Mll protein. Thus, the biological features of the Mll* protein remain obscure. Another plausible explanation would be that the Mll* protein leads to an excess of Mll Á C protein fragments that -after binding to the wild-type Mll . N protein fragmentsincrease the stability of these Mll multiprotein complexes by protecting them against proteolytical degradation (Yokoyama et al., 2002) . (2) The established Mll knockout model exhibited embryonal lethality (Yu et al., 1995) . Mll À/À embryos dies in utero at day 10.5. According to the data obtained in this study, this Mll k.o. strain is still able to express the Mll* protein. Thus, embryonal lethality may not associated with a missing C-terminus of the Mll protein, rather than the physical separation of N-(Menin1-binding region and AT-hooks) and C-terminal Mll protein sequences (protein-interaction domains, enzymatic SET-domain). Missing Mll protein sequences are the MT-domain and the PHD fingers 1-3, respectively. (3) An important prediction can be made for leukaemia patients carrying specific MLL translocations. Depending on where a chromosomal translocation occurred in a given leukaemia patient (SCI or SCII), the gene-internal promoter is retained on one of the resulting derivative chromosomes. Thus, leukaemic cells are either able to transcribe and translate the MLL* protein (when recombined at SCI), or, portions of the fused translocation partner gene (when recombined at SCII). Search for bona-fide AUG start codons in the most frequently fused MLL translocation partner genes revealed potential start codons in the fused protein fragments of AF4, AF6 and ENL, but not of AF9. These details have to be investigated in the future by using either cell lines derived from such patients or primary biopsy material to investigate whether this particular feature has any importance for the pathology of MLL-mediated leukaemias.
In summary, the presented data provide novel insights into MLL biology and uncovered a novel feature of the MLL/Mll gene of the human and mouse system. These findings might be of importance for disease mechanism(s) exerted by recombined MLL alleles.
Material and methods
Gene expression profiling experiments
Total RNA was isolated from MLL À/À and isogenic MLL þ / þ control cell lines on three independent days, mixed and used for hybridization of Mouse Genome 430 2.0 arrays. All experiments were replicated twice in order to identify up-and downregulated genes. Gene list were created by using only significantly changed gene signatures (D>2-fold). All Affymetrix experiments were performed on the NGFN II Affymetrix working platform in Essen (L Klein-Hitpass). Comparison analysis was performed by using the database program FileMaker. Complete lists of gene expression profiles are available upon request.
RT-PCR experiments
Total RNA was isolated from 1 Â 10 7 cells and tested for the absence of genomic DNA. RT-PCR was performed by using the touchdown protocol. The following oligonucleotides were used for transcript mapping:
0 -GCCTCTTCTGG TTTGTGGAA-3 0 ); 37 . 5 (5 0 -CAT CAATTCGGAACATG TAGC-3 0 ). Transcript fine mapping within the murine Mll gene was performed by using the oligonucleotides: 10 .
0 ), and 18 . 5. All PCR products were resolved on 1-2% agarose gels and visualized by ethidium bromide staining. Negative controls were performed for all reactions. GAPDH oligonucleotides were GAPDH Á 3 (5 0 -CTTCACCACCATGGAGAAGG-3 0 ) and GAPDH . 5 (5 0 -CCTGCTTCACCACCTTCTTG-3 0 ).
Cloning and transient transfection of the human and mouse gene-internal promoter elements Plasmid pGL3-A h (À492/ex12/ þ 768) was generated by PCR using the oligonucleotides Prom Á 3-XhoI (5 0 -CCGCTCGAG CAGTGAGTCGAGATCGCACC-3 0 ) and Prom . 5-HindIII (5 0 -CCCAAGCTTCCCAAAATTAAAACACAAAATAGG-3 0 ). An arbitrary splice acceptor site (5 0 -AAGCTTTTTGCCAT TATATTTTCTTACAGCAGCAAGCTT-3 0 ) was cloned into a singular HindIII restriction site to guarantee splicing between exon 12 and the luciferase reporter gene. Plasmids pGL3-B h (À35/ex12/ þ 768) and pGL3-C h (À492/ex12D) were constructed accordingly by using the oligonucleotides Prom2 . 3-XhoI (5 0 -ccgctcgagTGACATACTTCTATCTTCCCAT-3 0 and Prom3 . 5-Hind (5 0 -cccaagcttAAGGGCTCAACACAGACTT GG-3 0 ). A similar strategy was applied to obtain the 3 mouse promoter constructs pGL3-A/B/C m , except that the natural splice site of Mll exon 13 was fused in frame to the Luciferase open reading frame. All constructs were transiently cotransfected in 4 Â 10 4 HeLa cells by using calcium phosphate DNA-precipitates of 1 mg Luciferase and 20 ng pSEAP plasmid (internal control).
Gene reporter experiments
Gene reporter experiments were performed using pGL3-Luciferase plasmids as described (Uhl et al., 2002) . The promoter-less pGL3-Basic vector was used as negative control, while a SV40 promoter::luciferase expression construct served as positive control (pGL3-SV40). All experiments were performed independently three times in triplicates.
Western blot experiments (10 7 ) Cells were lysed for 20 min at 41C in buffer A (20 mM Hepes pH 7.7, 150 mM NaCl, 1% Triton X-100 and 0.4 mM ethylenediamine-N,N,N 0 ,N 0 -tetraacetic acid (EDTA)). After centrifugation (20 min, 14.000 Â g, 41C), the supernatant was stored (S150). The nuclei pellet was incubated for 20 min at 41C in buffer B (20 mM Hepes pH 7.7, 450 mM NaCl, 1% Triton X-100 and 0.4 mM EDTA). After centrifugation (20 min, 14.000 Â g, 41C), supernatant were collected (S450). Immunoprecipitations using the polyclonal antiserum 173 (PAS173) were performed from whole cell lysates prepared from 10 7 or 2 Â 10 7 cells using lysis buffer A. Supernatant were used for sodium dodecyl sulphate (SDS)-page analysis and Western blot experiments. Western blots were probed either with the MAB E28 (raised against the human MLL protein sequence 2328-2660) or the PAS173 specific for the human MLL . C protein fragment (Nakamura et al., 2002) .
Immunohistological experiments
For immunohistochemical analyses, 5 Â 10 3 cells of MLL
and MLL À/À cell lines were seeded in chamberslides (Lab-Tec Chambered Coverglass System, Nalge Nunc International, Neerijse, Belgium). Cells were incubated in a humidified incubator (Dulbecco's modified Eagle's medium, 10% foetal calf serum, 5.0% C0 2 , 371C) until a 70% confluence was reached. Cells were fixed by removing the medium, the addition of À201C cold methanol and incubation for 8 min at À201C. After removing the methanol, cells were rehydrated with phosphate-buffered saline (PBS) for 2-3 min at room temperature (RT). Cells were permeabilized in PBS/Triton X-100 (0.1%) for additional 3 min. Blocking solution (10% Normal goat serum in 1 Â PBS, Sigma) was added and incubated for 30 min at RT. After removal of the blocking solution, monoclonal antibodies (MAB E3; MAB E28) were added in PBS/Triton X-100 (0.1%) and incubated for 1 h at 371C. As negative control, 1% normal goat serum in PBS was used instead of the MLL-specific monoclonal antibodies.
All cell monolayers were washed three times with PBS/ Triton X-100 (0.1%) for 5 min at RT. The secondary antibody, a goat anti-Mouse-IgM-fluorescein isothiocyanate (FITC) or a goat anti-Mouse-IgG-FITC monoclonal (ICN), was diluted 1/ 250 in PBS/1% normal goat serum and added to the fixed cells. After incubation for 30 min at RT, all samples were washed three times with PBS/Triton X-100 (0.1%) for 5 min at RT. To avoid fluorescence fading, the SlowFadeLight Antifade Kit was added as recommended by the manufacturer (Molecular Probes, (MoBiTec) Go¨ttingen, Germany). Cell monolayers were directly analysed by confocal laser scanning microscopy (CLSM; Leica Lasertechnik). Data obtained by CLSM (excitation l ¼ 485 nm) were processed by using Imaris-and Selima-software.
Chromatin immunoprecipitation experiments
Cells were grown to 90% confluence, washed and crosslinked with 1% formaldehyde at RT for 10 min. Cells were collected and washed two times with 10 ml ice-cold PBS, centrifuged and then resuspended in 2 ml of lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl pH8.1) and sonicated three times for 15 s each at the maximum setting. Supernatants were then recovered by centrifugation at 12.000 r.p.m. for 10 min at 41C, diluted 3 to 10 times in dilution buffer (0.5% Triton X-100, 2 mM EDTA, 100 mM NaCI, 20 mM Tris-HCl pH8.1) and subjected to one round of immunoclearing for 2 h at 41C with 2 mg sheared salmon sperm DNA, 2.5 mg preimmune serum and 50 ml of protein A sepharose (of 50% slurry). Immunoprecipitation was performed overnight with specific antibodies, then 2 mg sheared salmon sperm DNA and 60 ml of protein A sepharose (of 50% slurry) were further added for 1 h at 41C. Immunoprecipitates were washed consecutively for 10 min each in TSE I (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HC1 pH8.1, 150 mM NaCI), TSE II (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HC1 pH8.1, 500 mM NaCl) and buffer III (0.25 M LiCl, 1% Sigma IGEPAL CA-630, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-HCI pH8.1). Beads precipitates were then washed two times with TE buffer pH8.0 and eluted with 1% SDS, 0.1 M NaHCO 3 . Crosslinks were reversed by incubating samples at 651C overnight, and samples were then incubated for 1 h at 451C with 0.5 M EDTA, 1 M Tris pH 6.5, proteinase K and RNaseA and DNA was precipitated using classical procedures. Pellets were resuspended in 100 ml sterile water and assayed by semiquantitative PCR. Thirty cycles of PCR were performed in 50 ml reactions using 90, 30 and 10 ng of immunoprecipitated material, 10 pmol of each primer set, 0.125 units of Taq DNA polymerase (Eppendorf). Each experiment was performed at least three times and representative data are shown.
In situ hybridization of mouse sections and RT-PCR analyses Sense and antisense probes for in situ hybridization were PCR amplified using the Mll exon 4 specific primers M4 . 3 (5 0 -GCCTCCATCCACAGAACGG-3 0 ) X M4 . 5 (5 0 -AGAGG CCTGAGAATCTGAGG-3 0 ) and the Mll ex28 specific primer M28 . 3 (5 0 -GGTTCATAACGCAACTCCTGG-3) X M28 . 5 (5 0 -GGGTGCCTGTAACTCCTTGG-3 0 ) and cloned into the pGEMT vector (Promega, Mannheim, Germany). Whole mouse embryos were frozen in OCT (Merck) on dry ice, and 15 mM sections were cut and mounted on positively charged slides. Dioxygenin (DIG)-labeled riboprobe synthesis and hybridization were performed using standard procedures. After overnight exposure to the anti-DIG antibody, slides were exposed to NBT/BCIP for 20 h before slide washing and mounting. RNA for RT-PCR analysis was purified from dissected whole embryos at E9.5 and E11.5 using the RNeasy mini kit (Qiagen, Hilden, Germany); amplification was carried out using 30 PCR cycles.
Identification of etoposide-induced DNA DSBs in subcluster II of the human MLL gene Cell lines (REH or Jurkat) and freshly prepared PBMCs were incubated with 20 mM VP16 for 16 h. Genomic DNA from treated and untreated cells was isolated, and 5 mg of isolated genomic DNA was digested overnight with EcoRI/BamHI (50U each). After fill-in reaction and ligation, genomic DNA circles were investigated by inverse PCR reactions using the oligonucleotide combinations I11 . 58 (5 0 -AGAGAACATAT TAACACTTAGG-3 0 ) and I11 . 34 (5 0 -TTAACACACTGG TACATTAC-3 0 ) in order to amplify genomic MLL sequence (wild-type or broken DNA; see Figure 8 , white triangles). Control reactions using the oligonucleotide combination 4 . 56 (5 0 -CTGTAAGAGTTGCTTAGCA-3 0 ) and 4 . 34 (5 0 -GTT TTGGATCTAGAACGACGA-3 0 ; specific for MLL exon 4 region), or 15 . 5 (5 0 -CATCATAACATTTGTCACAGAG-3 0 ) and 16 . 3 (5 0 -ATCTGCCAGAAAGTGTGGC-3 0 ; specific for MLL exons 15 and 16) resulted only in germline DNA amplimers (data not shown). The highest number of clones representing individual DNA strand breaks were obtained from Jurkat cells (17 without treatment, 77 with treatment), while for PBMCs (8 without treatment, 23 with treatment) and REH cells (19 without treatment, 25 with treatment) much less clones were analysed. Most DNA strand breaks were localized in a 100 nucleotide long area (À75 to þ 25 nt relative to the first nucleotide of MLL exon 12). In control reactions, most DNA strand breaks were identified at a conserved Topo II consensus sequence located within MLL exon12.
